EUVIMEDEUVIMED entdecken
Querschnittstudie

Association between systemic inflammation-immune index and comorbidities in patients with ankylosing spondylitis: a cross-sectional study

Jiang Xiao, Nan Lin, Zixin Xu, Yujie Jiang, Xinyi Wang, Yan Sang

Clinical Rheumatology · 2026-06 · 45 (6) · 3327-3338

DOI: 10.1007/s10067-026-08048-4 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Clinical Rheumatology, online erschienen am 24.03.2026. Verfasst von Jiang Xiao und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing and Rehabilitation, Nantong University, Nantong, Jiangsu, China. Hauptthemen laut MEDLINE: Spondylitis, Ankylosing, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: The Scientific Research Project of Nantong Municipal Health Commission, Science and Technology Project of Nantong City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: The systemic inflammation-immune index (SII) is a biomarker for various diseases; however, its relationship with comorbidities in ankylosing spondylitis (AS) remains unclear. This study aimed to investigate the relationship between SII and the comorbidities associated with AS. METHOD: The cross-sectional study collected data from 688 patients treated at a grade A tertiary hospital in Jiangsu Province between 2021 and 2025. The SII was calculated based on platelet, neutrophil, and lymphocyte counts. Logistic regression analyses were performed. The nonlinear relationship between SII and comorbidities was examined using restricted cubic splines, and interactions between groups were identified through the likelihood ratio test. RESULTS: A total of 688 patients were included in the study: 233 with comorbidities and 455 without. The average age was 52.0 ± 14.4 years, with 68.8% being male and 31.2% being female. The incidence of comorbidities was 33.9%. After adjusting for certain covariates, a positive correlation between the SII and comorbidities (OR = 1.3, 95% CI [1.03, 1.64], P = 0.025) was observed, indicating independence from other confounding factors. A non-linear relationship was found between SII and the incidence of comorbidities, with a threshold of approximately 458. Subgroup analysis revealed a significant interaction between SII and disease duration/HLA-B27 (P for interaction < 0.05). A significant additive interaction was observed between SII and disease duration of over 10 years (RERI = 2.49, 95% CI [0.46, 4.52]; AP = 0.52, 95% CI [0.25, 0.79]; SI = 2.92, 95% CI [1.09, 7.85]; P = 0.01). A significant multiplicative interaction exists between HLA-B27( +) and high SII (OR = 2.5, P = 0.03). CONCLUSIONS: A substantial correlation exists between SII and AS comorbidities, indicating its potential as a predictive biomarker. Key Points • A substantial correlation exists between SII and AS comorbidities. • A non-linear relationship was found between SII and the incidence of comorbidities. • Subgroup analysis revealed a significant interaction between SII and disease duration/HLA-B27.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spondylitis, AnkylosingInflammationHumansFemaleMaleCross-Sectional StudiesMiddle AgedComorbidityAdultAgedChinaSeverity of Illness IndexLogistic ModelsBiomarkers

Stichwörter der Autor:innen

Ankylosing spondylitisBiomarkersComorbiditiesCross-sectional studyInflammation

Substanzen

Biomarkers

Autor:innen und Institutionen

  • School of Nursing and Rehabilitation, Nantong University, Nantong, Jiangsu, China.
  • Medical School of Nantong University, Nantong, Jiangsu, China.
  • Department of Computer Technology, Affiliated Hospital of Nantong University, Nantong, 226007, Jiangsu, China. sangyan_cn@126.com.

Förderung

  • The Scientific Research Project of Nantong Municipal Health Commission
  • Science and Technology Project of Nantong City

Zitieren

APA

Xiao, J., Lin, N., Xu, Z., Jiang, Y., Wang, X., & Sang, Y. (2026). Association between systemic inflammation-immune index and comorbidities in patients with ankylosing spondylitis: a cross-sectional study. Clinical Rheumatology, 45(6), 3327-3338. https://doi.org/10.1007/s10067-026-08048-4

Vancouver

Xiao J, Lin N, Xu Z, Jiang Y, Wang X, Sang Y. Association between systemic inflammation-immune index and comorbidities in patients with ankylosing spondylitis: a cross-sectional study. Clinical Rheumatology. 2026;45(6):3327-3338. doi:10.1007/s10067-026-08048-4

BibTeX
@article{Xiao2026,
  author = {Xiao, Jiang and Lin, Nan and Xu, Zixin and Jiang, Yujie and Wang, Xinyi and Sang, Yan},
  title = {Association between systemic inflammation-immune index and comorbidities in patients with ankylosing spondylitis: a cross-sectional study},
  journal = {Clinical Rheumatology},
  year = {2026},
  volume = {45},
  number = {6},
  pages = {3327--3338},
  doi = {10.1007/s10067-026-08048-4}
}
Kostenlos starten →